Loading drugs…
Loading drugs…
Drugs
One entity per molecule (INN preferred); brand names and development codes are aliases. Approvals are always shown with jurisdiction and indication.
820 drugs
| Drug | Kind | Mechanism | Approvals | Evidence items | Trials | Identifiers |
|---|---|---|---|---|---|---|
| ARQ092 | Small Molecule | Serine/threonine-protein kinase AKT inhibitor | 0 | 1 | 2 | CHEMBL4297188 |
| ARS-853 | — | — | 0 | 1 | 0 | — |
| AS602868 | — | — | 0 | 1 | 0 | — |
| Aurora A Kinase Inhibitor LY3295668 Erbumine | — | — | 0 | 1 | 3 | C165238 |
| Avutometinib And Defactinib | — | — | 0 | 1 | 5 | C217093 |
| AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M | — | — | 0 | 1 | 2 | C132025 |
| AZ12908010 | — | — | 0 | 1 | 0 | — |
| AZ20 | — | — | 0 | 1 | 0 | — |
| AZ628 | — | — | 0 | 1 | 0 | — |
| AZ909 | — | — | 0 | 1 | 0 | — |
| AZD5438 | — | — | 0 | 1 | 1 | — |
| Barasertib | Small Molecule | Serine/threonine-protein kinase Aurora-B inhibitor | 0 | 1 | 12 | C62502 · CHEMBL415049 |
| BCR-ABL Inhibitor HS-10382 | — | — | 0 | 1 | 1 | C187661 |
| Befotertinib | Small Molecule | — | 0 | 1 | 8 | C175747 · CHEMBL5095167 |
| Berzosertib | Small Molecule | Serine-protein kinase ATR inhibitor | 0 | 1 | 21 | C116355 · CHEMBL3989870 |
| Bevacizumab/Lomustine Regimen | — | — | 0 | 1 | 0 | C160526 |
| Bimiralisib | Small Molecule | — | 0 | 1 | 10 | C111898 · CHEMBL4084907 |
| BMVC-8C3O | — | — | 0 | 1 | 0 | — |
| Bone Marrow Transplantation | — | — | 0 | 1 | 3 | C15194 |
| C646 | — | — | 0 | 1 | 0 | — |
| Camptothecin | Small Molecule | — | 0 | 1 | 0 | C338 · CHEMBL65 |
| Camrelizumab | Monoclonal Antibody | Programmed cell death protein 1 antagonist | 0 | 1 | 288 | C123816 · CHEMBL4297715 |
| CAN508 | — | — | 0 | 1 | 0 | — |
| CAPOX Regimen | — | — | 0 | 1 | 66 | C63596 |
| Carboplatin OR Cisplatin | — | — | 0 | 1 | 11 | — |
| C-DIM 12 | — | — | 0 | 1 | 0 | — |
| Cetuximab/Encorafenib Regimen | — | — | 0 | 1 | 0 | C171194 |
| Cetuximab/Irinotecan Regimen | — | — | 0 | 1 | 2 | C63606 |
| CH6953755 | — | — | 0 | 1 | 0 | — |
| CH7233163 | — | — | 0 | 1 | 0 | — |
| Chemoimmunotherapy | — | — | 0 | 1 | 3 | C94251 |
| Chemoradiotherapy | — | — | 0 | 1 | 10 | C94626 |
| CHMFL-KIT-031 | — | — | 0 | 1 | 0 | — |
| CHOP Regimen | — | — | 0 | 1 | 22 | C63450 |
| CHZ868 | — | — | 0 | 1 | 0 | — |
| Cixutumumab | Monoclonal Antibody | Insulin-like growth factor I receptor antagonist | 0 | 1 | 43 | C79828 · CHEMBL1743001 |
| Claturafenib | Small Molecule | — | 0 | 1 | 2 | C191953 · CHEMBL6068425 |
| C-Met Inhibitor | — | — | 0 | 1 | 0 | C143099 |
| Conatumumab | Monoclonal Antibody | Tumor necrosis factor receptor superfamily member 10B agonist | 0 | 1 | 11 | C71015 · CHEMBL1743003 |
| CTLA-4 Inhibitor | — | — | 0 | 1 | 1 | — |
| Cyproterone Acetate | Small Molecule | Androgen Receptor antagonist; Glucocorticoid receptor antagonist; Progesterone receptor agonist | 0 | 1 | 12 | C1059 · CHEMBL139835 |
| Cytoreductive Surgery | — | — | 0 | 1 | 0 | C132068 |
| Daromun | — | — | 0 | 1 | 9 | C154627 |
| Datopotamab Deruxtecan Regimen | — | — | 0 | 1 | 0 | C213229 |
| Disitamab Vedotin | Adc | Receptor tyrosine-protein kinase erbB-2 binding agent; Tubulin disrupting agent | 0 | 1 | 60 | C169918 · CHEMBL5095273 |
| Divarasib | Small Molecule | — | 0 | 1 | 12 | C173995 · CHEMBL5095236 |
| Donor Lymphocyte Infusion | — | — | 0 | 1 | 12 | C16145 |
| DS-6501b | — | — | 0 | 1 | 0 | — |
| Durvalumab Regimen | — | — | 0 | 1 | 0 | C160026 |
| DVP Regimen | — | — | 0 | 1 | 0 | C9656 |